Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-read sequencing for molecular diagnostics in constitutional genetic disorders. | Hum Mutat | 2022 | 36086952 | PubTator, text mining | PubMed |
| Bone marrow free immune checkpoints as a potential biomarker for differential diagnosis of acquired bone marrow failures. | J Clin Lab Anal | 2022 | 36086857 | PubTator, text mining | PubMed |
| Phase separation in epigenetics and cancer stem cells. | Front Oncol | 2022 | 36081552 | PubTator, text mining | PubMed |
| Rough Surface Characterization Parameter Set and Redundant Parameter Set for Surface Modeling and Performance Research. | Materials (Basel) | 2022 | 36079350 | PubTator, text mining | PubMed |
| Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis. | J Clin Med | 2022 | 36079017 | PubTator, text mining | PubMed |
| Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling. | Cancers (Basel) | 2022 | 36077653 | PubTator, text mining | PubMed |
| Roles of Antimicrobial Peptides in Gynecological Cancers. | Int J Mol Sci | 2022 | 36077500 | PubTator, text mining | PubMed |
| HOX-Gene Cluster Organization and Genome Duplications in Fishes and Mammals: Transcript Variant Distribution along the Anterior-Posterior Axis. | Int J Mol Sci | 2022 | 36077385 | PubTator, text mining | PubMed |
| Reorganization of the Landscape of Translated mRNAs in NSUN2-Deficient Cells and Specific Features of NSUN2 Target mRNAs. | Int J Mol Sci | 2022 | 36077143 | PubTator, text mining | PubMed |
| A novel variant in the ROR2 gene underlying brachydactyly type B: a case report. | BMC Pediatr | 2022 | 36064339 | PubTator, text mining | PubMed |
| Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis. | J Neuroimmunol | 2022 | 36054935 | PubTator, text mining | PubMed |
| Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection. | Front Immunol | 2022 | 36045684 | PubTator, text mining | PubMed |
| Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives. | Cell Commun Signal | 2022 | 36038915 | PubTator, text mining | PubMed |
| Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis. | Int J Med Sci | 2022 | 36035368 | PubTator, text mining | PubMed |
| Developmental genomics of limb malformations: Allelic series in association with gene dosage effects contribute to the clinical variability. | HGG Adv | 2022 | 36035248 | PubTator, text mining | PubMed |
| Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis. | Front Immunol | 2022 | 36032076 | PubTator, text mining | PubMed |
| Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently? | Front Immunol | 2022 | 36003388 | PubTator, text mining | PubMed |
| Rational Nanomedicine Design Enhances Clinically Physical Treatment-Inspired or Combined Immunotherapy. | Adv Sci (Weinh) | 2022 | 36002305 | PubTator, text mining | PubMed |
| Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts. | Front Genet | 2022 | 35983412 | PubTator, text mining | PubMed |
| A context-dependent and disordered ubiquitin-binding motif. | Cell Mol Life Sci | 2022 | 35974206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=21